Research uncovers role of Apolipoprotein E in Alzheimer’s disease
Inhibiting Apolipoprotein E possible means of therapeutic intervention for Alzheimers disease
A research team led by University of South Florida neuroscientist Huntington Potter, PhD, CEO of the Johnnie B. Byrd Sr. Alzheimers Center & Research Institute, for the first time has defined how the protein Apolipoprotein E (ApoE) contributes to both the formation of amyloid brain lesions and the memory loss associated with Alzheimers disease. The research, conducted jointly by USF and the Byrd Institute, is published in the October 2004 issues of the Journal of Alzheimers Disease and the Neurobiology of Aging.
Previous work has shown that the inflammatory protein ApoE can speed the buildup in the brain of amyloid plaques, the major pathological hallmark of Alzheimers disease. These deposits of plaques are composed primarily of the amyloid-beta protein (AB). However, the mechanism by which ApoE exerted its ill effects on Alzheimers disease was unclear.
In the first paper*, published in the Journal of Alzheimers Disease, the USF/Byrd Institute team found that ApoE is responsible for converting harmless AB into the toxic fibrous deposits, known as filamentous amyloid. The researchers showed that mice with ApoE possessed 3200 times more filamentous amyloid than those without the gene. Diffuse deposits of AB can occur in the elderly in the absence of Alzheimers disease, and are thought to be a normal aspect of aging, while filamentous amyloid is a toxic product of Alzheimers disease.
In the second paper**, published in the Neurobiology of Aging, the researchers indicate that the process of altering AB from its diffuse form into filamentous amyloid is needed to damage nerve cells in parts of the brain controlling memory and cognition. Mice with Alzheimers disease showed memory deficits only when the ApoE gene was present.
“The implication of these studies is that the amyloid promoting activity of ApoE is essential for the development of both Alzheimers pathology and cognitive decline,” said Dr. Potter, professor of biochemistry and molecular biology who holds the Pfeiffer Endowed Chair in Alzheimers Research at USF. “Thus, preventing ApoE from acting upon AB may prove to be an effective means of therapeutic intervention.”
Media Contact
More Information:
http://www.hsc.usf.eduAll latest news from the category: Life Sciences and Chemistry
Articles and reports from the Life Sciences and chemistry area deal with applied and basic research into modern biology, chemistry and human medicine.
Valuable information can be found on a range of life sciences fields including bacteriology, biochemistry, bionics, bioinformatics, biophysics, biotechnology, genetics, geobotany, human biology, marine biology, microbiology, molecular biology, cellular biology, zoology, bioinorganic chemistry, microchemistry and environmental chemistry.
Newest articles
Recovering phosphorus from sewage sludge ash
Chemical and heat treatment of sewage sludge can recover phosphorus in a process that could help address the problem of diminishing supplies of phosphorus ores. Valuable supplies of phosphorus could…
Efficient, sustainable and cost-effective hybrid energy storage system for modern power grids
EU project HyFlow: Over three years of research, the consortium of the EU project HyFlow has successfully developed a highly efficient, sustainable, and cost-effective hybrid energy storage system (HESS) that…
After 25 years, researchers uncover genetic cause of rare neurological disease
Some families call it a trial of faith. Others just call it a curse. The progressive neurological disease known as spinocerebellar ataxia 4 (SCA4) is a rare condition, but its…